Talledo, Inocenta D.
HRN: 04-48-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2024
CEFTRIAXONE 1G (VIAL)
05/06/2024
05/13/2024
IV
1g
Q12
Fracture For OR
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & JointProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes